2020
DOI: 10.1007/s00396-019-04593-4
|View full text |Cite
|
Sign up to set email alerts
|

Identification of aqueous reservoirs in poly(alkylcyanoacrylate) nanoparticles

Abstract: Poly (n-butylcyanocrylate) nanocapsules were obtained by interfacial polymerization from a water-in-oil microemulsion. The latter was composed of pharmaceutically acceptable excipients such as Labrafac lipophile WL 1349 (oil), Plurol oleique CC497 (surfactant), Labrasol (co-surfactant) and was able to incorporate 20% aqueous phase. Pure n-butyl cyanoacrylate monomer (without any dilution in a halogenated solvent) was added to the microemulsion in order to obtain an oily suspension of biocompatible and biodegra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 26 publications
0
1
0
Order By: Relevance
“…Pharmaceutical/formation excipients enhanced the drug potency by inhibiting the drug metabolic pathway or transporter proteins (Veeravalli et al, 2020). Now a day, several surfactants and many natural and synthetic polymeric excipients (Table 2) are used in pharmaceutical formulation as well as in novel drug delivery systems to overcome the effects of P‐gp and deliver the therapeutic agents at the targeted place (Jeganathan et al, 2020; Thomas et al, 2020; Katekar et al, 2020; Mokhtar et al, 2019; Sulheim et al, 2016; Zhang et al, 2017; Liu et al, 2017; Watkins et al, 2017; Valicherla et al, 2016; Hoosain et al, 2015; Constantinides & Wasan, 2007; Veeravalli et al, 2020; Jacob et al, 2020). Berberine (benzylisoquinoline alkaloid) C max , AUC and relative oral bioavailability (404%) enhanced when loaded in Brij‐S20‐modified nanocrystal formulation (Xiong et al, 2018).…”
Section: Approaches To Overcome the Effects Of P‐gpmentioning
confidence: 99%
“…Pharmaceutical/formation excipients enhanced the drug potency by inhibiting the drug metabolic pathway or transporter proteins (Veeravalli et al, 2020). Now a day, several surfactants and many natural and synthetic polymeric excipients (Table 2) are used in pharmaceutical formulation as well as in novel drug delivery systems to overcome the effects of P‐gp and deliver the therapeutic agents at the targeted place (Jeganathan et al, 2020; Thomas et al, 2020; Katekar et al, 2020; Mokhtar et al, 2019; Sulheim et al, 2016; Zhang et al, 2017; Liu et al, 2017; Watkins et al, 2017; Valicherla et al, 2016; Hoosain et al, 2015; Constantinides & Wasan, 2007; Veeravalli et al, 2020; Jacob et al, 2020). Berberine (benzylisoquinoline alkaloid) C max , AUC and relative oral bioavailability (404%) enhanced when loaded in Brij‐S20‐modified nanocrystal formulation (Xiong et al, 2018).…”
Section: Approaches To Overcome the Effects Of P‐gpmentioning
confidence: 99%